Sorted By:


Questions and Answers for Peer Speakers Program for Health Care Professionals

PhRMA  |  Report

Why do biopharmaceutical companies sponsor peer speaker programs for health care professionals? Doctors and other healthcare professionals with real-world clinical experience in specific therapeutic areas are uniquely qualified to educate and inform their peers about the ...

Ebola: The Biopharm Industry Committed to Advancements

PhRMA  |  Report

Researchers around the world, from both the public and private sectors, are increasingly working collaboratively to develop new ways to prevent the spread of Ebola and treat patients who have contracted the virus. The research and development process for new medicines is a lengthy, challenging an...

PhRMA Kicks Off National Health Care Dialogue to Examine the New Era of Medicine

PhRMA  |  Press Release

For reporters interested in speaking with The Atlantic, please contact Sydney Simon at

Prescription Drug Misuse, Abuse & Disposal

PhRMA  |  From PhRMA

PhRMA has several alliances with organizations working to prevent prescription drug abuse: The Partnership for Drug-Free Kids Medicine Abuse Project, which provides comprehensive resources for parents and caregivers, law enforcement officials, health care providers, educators and others so that everyone can take a stand and help end medicine abuse.

PhRMA to Present the 2017 Research & Hope Awards for Outstanding Mental Health Advocacy and Research

PhRMA  |  Press Release

To learn more about the Research and Hope Award winners, please visit: To learn more about the GOBOLDLY campaign and view the Together ads, please visit: “Medicines in Development for Mental Illness” can be downloaded at: About PhRMAThe Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives.

How drug importation schemes could increase U.S. law enforcement burdens

PhRMA  |  Blog Post

With large-scale importation proposals, we can’t ignore the danger of overwhelming already overburdened law enforcement agencies with increased counterfeit products, including opioids.

Innovation Spotlight: What is the Future of Health Care?

PhRMA  |  Video

The speakers also touched upon policy solutions to advance market-based reforms that promote competition and modernize the drug discovery and development process.

Trends in Weighted Average Sales Prices for Prescription Drugs in Medicare Part B, 2006-2014

PhRMA  |  Report

Research on the pricing of prescription drugs tends to focus on individual products, rather than the overall pricing trend for the market as a whole. This larger trend—which is influenced by multiple competitive forces, including competition among products in therapeutic classes and entry of gene...

Research in Connecticut

PhRMA  |  Research In Your Backyard

This report shows that biopharmaceutical research companies continue to be vitally important to the economy and patient health in Connecticut, despite the recession.

Medicare Monday: How existing CMMI models affect Medicare Part B

PhRMA  |  Blog Post

American Society for Clinical Oncology said, “The Part B Model would remove resources from practices as they prepare for changes under MACRA.

Earth Day 2015: Green Initiatives are Good for Business and the Environment

PhRMA  |  Blog Post

Eco-friendly facilities like this can play an important role in conserving our natural resources.

PhRMA Statement on Trump Opioids Announcement

PhRMA  |  Press Release

This includes endorsing the comprehensive approach recommended by the President’s Commission on Combatting Drug Addiction and Opioid Abuse in their interim report.

Quantifying Improvements in Life Quality of Individuals with Complex Chronic Medical Conditions Over the Past Decade

PhRMA  |  Report

Over the past decade, biopharmaceutical researchers have leveraged new technologies and growing scientific knowledge about disease mechanisms to develop sophisticated and comprehensive treatments to complex medical conditions. This paper seeks to analyze and highlight the extent of progress that ...

Opening the conversation around mental health treatment with advocates & industry leaders

PhRMA  |  Blog Post

To learn more about medicines in development for mental health, click here.

Research In Your Backyard

PhRMA  |  From PhRMA

Click any state below to access the full report for that state.

New Study: Substantial rebates negotiated in Medicare Part D

PhRMA  |  Blog Post

This report is further evidence of the robust negotiating power of Part D plans and how they secure rebates and discounts to keep costs low for beneficiaries and taxpayers.

340B Spotlight: Program continues to grow with no end in sight

PhRMA  |  Blog Post

[3] Avalere Health analysis of Health Resources and Services Administration Office of Pharmacy Affairs 340B Database.

Director of Application Support and Business Intelligence – Information Technology

PhRMA  |  PhRMA Career

Professional Experience / Requirements  Bachelor’s degree or equivalent knowledge and experience; Experience with financial management and CRM systems; Experience in creating queries, reports, and dashboards using native reporting tools, SSRS, and Power BI; Excellent interpersonal, written and verbal communication skills; Ability to explain technical concepts to a non-technical audience; Ability to handle multiple responsibilities in a dynamic environment; Ability to work across departmental boundaries; Must be available as needed after hours and on weekends to facilitate planned maintenance as well as address emergency problems.

Are insurers exaggerating medicine costs to justify premium increases? Consumers think so.

PhRMA  |  Blog Post

It’s a dramatic decline from the 8.5 percent increase that Altarum reported last year and the 12.5 percent annual increase the year before that.

Medicare Monday: Medicare turns 52!

PhRMA  |  Blog Post

Read on here and be sure to tune into Medicare Monday each week for updates and new resources on all things Medicare.

Medicare Monday: Open enrollment ends December 7! Last call to shop around

PhRMA  |  Blog Post

Throughout the fall, we’ve shared resources for reviewing your plan options and making a selection and reviewed the benefits of switching plans—even if your premium may be going down next year.

PhRMA Statement on Prescription Drug Importation

PhRMA  |  Press Release

For this reason, PhRMA believes that Congress should continue to maintain – not weaken – FDA’s relatively closed drug supply system and also ensure that CBP and FDA have the resources to seize potentially dangerous and counterfeit products at our nation’s borders.

Foreign government pricing setting by any name harms innovation and access to medicines

PhRMA  |  Blog Post

This approach disregards important differences among countries that impact prices and imports bad policies from abroad.

ICYMI: What the experts are saying about importation

PhRMA  |  Blog Post

Bloomberg BNA reports that Tim Squire, a partner in the Toronto office of Fasken Martineau DuMoulin LLP and revered expert, said, “Canada's pricing controls don't apply to exports, so there is no guarantee Canadian products would be sold for the same prices in the United States…I don't think there are such huge savings to be had.”

What they are saying: Rising deductibles and out-of-pocket costs in health insurance plans

PhRMA  |  Blog Post

Associated Press reported following another recent report from Kaiser Family Foundation.

You have reviewed the first 300 results out of 1012. Each page contains 25 results. You're on page 12.

prev 7 8 9 10 11 12 next